Independent pharmacists and Big Pharma are working to eliminate the ability of self-funded plans to incentivize shopping at pharmacies with lower prices. Employers work to drive down costs by using lower co-pays to encourage patients to visit pharmacies that sell drugs at lower prices. Maryland lawmakers are considering outlawing the use of those incentives, using government control to rewrite private contracts.